We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKDA icon
12951
Arcadia Biosciences
RKDA
$1.5M
$67K ﹤0.01%
+1,617
New +$105K
SVRA icon
12952
CALL
Savara
SVRA
$1.11B
$67K ﹤0.01%
54,300
-5,500
-9% -$6.54K
TOMZ icon
12953
TOMI Environmental Solutions
TOMZ
$13.5M
$67K ﹤0.01%
13,575
+9,282
+216% +$41.3K
USIO icon
12954
CALL
Usio Inc
USIO
$78.6M
$67K ﹤0.01%
15,300
-17,800
-54% -$107K
SYRS
12955
PUT
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$67K ﹤0.01%
2,040
-4,940
-71% -$200K
NTBL
12956
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$67K ﹤0.01%
966
-1,646
-63% -$127K
TCON
12957
PUT
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$67K ﹤0.01%
1,205
-80
-6% -$5.11K
PRTK
12958
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$67K ﹤0.01%
15,000
+1,600
+12% +$7.59K
JOFFW
12959
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
$67K ﹤0.01%
95,089
-62,303
-40% -$46.6K
PHICW
12960
DELISTED
Population Health Investment Co., Inc. Warrant
PHICW
$67K ﹤0.01%
133,333
CEI
12961
CALL
DELISTED
Camber Energy, Inc
CEI
$67K ﹤0.01%
+1,576
New +$101K
AEMD icon
12962
Aethlon Medical
AEMD
$1.49M
$66K ﹤0.01%
+9
New +$102K
GORO icon
12963
PUT
Goldgroup Mining
GORO
$207M
$66K ﹤0.01%
42,500
-16,300
-28% -$29.6K
RAIL icon
12964
PUT
FreightCar America
RAIL
$240M
$66K ﹤0.01%
17,800
-8,100
-31% -$33.9K
WINT
12965
DELISTED
Windtree Therapeutics
WINT
$66K ﹤0.01%
+1
New +$80K
MTVA
12966
PUT
MetaVia Inc
MTVA
$7.69M
$66K ﹤0.01%
20
+3
+18% +$13.6K
DMK
12967
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$66K ﹤0.01%
1,547
-687
-31% -$42.8K
KRBP
12968
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$66K ﹤0.01%
1,444
+555
+62% +$37.8K
VOLT
12969
CALL
DELISTED
Volt Information Sciences, Inc.
VOLT
$66K ﹤0.01%
22,800
+1,800
+9% +$5.63K
NFH.WS
12970
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$66K ﹤0.01%
23,760
+2,042
+9% +$5.89K
FENC icon
12971
Fennec Pharmaceuticals
FENC
$411M
$65K ﹤0.01%
+14,874
New +$111K
MNOV icon
12972
MediciNova
MNOV
$64.5M
$65K ﹤0.01%
24,160
+11,028
+84% +$36.9K
ZYNE
12973
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$65K ﹤0.01%
22,600
-8,600
-28% -$31.8K
ILLM
12974
PUT
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$65K ﹤0.01%
17,400
+400
+2% +$1.89K
TLGA.WS
12975
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$65K ﹤0.01%
125,627
-53
-0% -$31

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.